Californians for Cures

The California Institute for Regenerative Medicine (CIRM)’s $3,000,000,000 over ten years is the largest source of embryonic stem cell research funding in the world. 
By early spring of 2008, the CIRM will have dedicated approximately $450 million to training, infrastructure, facilities and embryonic stem cell grants.  
In a small way, California was also the first state to fund embryonic stem cell research, through the Roman Reed Spinal Cord Injury Research Act of 1999.

Home

AB 750  The Roman Reed Spinal Cord Injury Research Act

The Stem Cell Research Enhancement Act

Stem Cells

SCI Statistics 

Contact Us

Relevant Links

Americans for Stem Cell Therapies and Cures

Stem Cell Battles

Cure Paralysis Now

Coalition for the Advancement of Medical Research

Genetics Policy Institute

The Reeve-Irvine Research Center

Research for Cure

Christopher Reeve Foundation

StemPac

Student Society for Stem Cell Research

United 2 Fight Paralysis - Working 2 Walk  April Conference in Washington D.C.
SIGN UP NOW

 

The Stem Cell Research Enhancement Act

 

Passed by the House of Representatives
and the Senate, TWICE,

Vetoed TWICE by President Bush .

  Below is the text of a CAMR letter just sent to President Bush.  

Thank you,  

Kim Love
CAMR 240-475-9424  

June 7, 2007  

George W. Bush
 President of the United States
The White House
Washington, DC 20500  

Dear Mr. President:  

I am writing to you on behalf of the Coalition for the Advancement of Medical Research (CAMR) and the broad and diverse community in support of the Stem Cell Research Enhancement Act (S.5).  An historic collection of groups remain united in support of this bill and the promise that it offers to end the suffering of 100 million patients and their families in our great nation.  Together, we are asking you to sign S. 5 into law.  

More than 100 million Americans suffer from cancer, Alzheimer's, diabetes, Parkinson's, spinal cord injuries, heart disease, ALS, and other debilitating diseases and disorders. Embryonic stem cell research holds the key to better treatments and cures, providing American families with hope for the future.  The American public supports this research and recent poll data indicate that nearly sixty (60) percent of Americans want you to sign the Stem Cell Research Enhancement Act into law.  

During the 109th Congress, the House of Representatives passed the Stem Cell Research Enhancement Act in 2005, followed by Senate passage in July 2006.   You vetoed this legislation, the first veto of your presidency, but now you have an opportunity to change the course of history with a second chance to sign the bill into law.   

The new leadership of the 110th Congress brought the Stem Cell Research Enhancement Act (H.R. 3) up for a vote and ultimately passage on January 11, 2007 in the U.S. House of Representatives and in the Senate on April 11, 2007.  The bill was amended in the Senate to include language from last year’s Specter-Santorum bill (S.2754).  This is legislative language that we understand you fully support.  This new bill, S.5, passed the House of Representatives by a strong majority on June 7, 2007.  

Please consider the suffering of millions as you decide the fate of S.5.  Your decision to sign the bill into law would translate into a renewed hope for those who have nowhere else to turn for cures and treatments.  Now is the time to expand federal support for embryonic stem cell research, opening possible doors to new knowledge, therapies and cures.  Your leadership is our best hope to make that happen.  

Sincerely, Sean Tipton
CAMR President  

Bush's Statement on Stem-Cell Bill
June 7, 2007 3:22 p.m.

President Bush Disappointed in House Vote on Embryonic Stem Cell Bill

Today, the United States House of Representatives, with its vote on the
embryonic stem cell bill, chose to discard existing protections on human
life. This bill puts scientific research and ethical principle into
conflict, rather than supporting a balanced approach that advances
scientific and medical frontiers without violating moral principles.

My Administration has sought to understand the dilemmas of stem cell
research not as a choice between science and ethics, but as a challenge
to advance medicine while meeting our solemn obligation to defend human
life. That is why in 2001 I authorized the first federal funding for
research on embryonic stem cells, under careful safeguards. This policy
encouraged ethical research, while requiring taxpayer funds not be used
to support the creation, destruction, or harming of living human
embryos.

Recent scientific developments have reinforced my conviction that stem
cell science can progress in ethical ways. Researchers have been
investigating innovative techniques that could allow doctors and
scientists to produce stem cells just as versatile as those derived from
human embryos, but without harming life, and the House vote on this bill
took place just after significant advances in stem cell research were
reported in leading scientific journals. These reports give us added
hope that we may one day enjoy the potential benefits of embryonic stem
cells without destroying human life.

I am disappointed the leadership of Congress recycled an old bill that
would simply overturn our country's carefully balanced policy on
embryonic stem cell research. If this bill were to become law, American
taxpayers would for the first time in our history be compelled to
support the deliberate destruction of human embryos. Crossing that line
would be a grave mistake. For that reason, I will veto the bill passed
today.

Source: White House